VistaGen Therapeutics, Inc.VTGNNASDAQ
Loading
Year-over-year debt growth rate
Latest
-23.49%
↓ 114% vs avg
Percentile
P21
Within normal range
Streak
2 qtr
Consecutive declineDecelerating
Average
169.88%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | -23.49% |
| Q3 2025 | -20.84% |
| Q2 2025 | 56.13% |
| Q1 2025 | -11.91% |
| Q4 2024 | -4.52% |
| Q3 2024 | -9.85% |
| Q2 2024 | -6.13% |
| Q1 2024 | -5.97% |
| Q4 2023 | -5.24% |
| Q3 2023 | -27.55% |
| Q2 2023 | 21.14% |
| Q1 2023 | -13.82% |
| Q4 2022 | -11.80% |
| Q3 2022 | -10.43% |
| Q2 2022 | 31.04% |
| Q1 2022 | -3.28% |
| Q4 2021 | -11.31% |
| Q3 2021 | -2.51% |
| Q2 2021 | -2.29% |
| Q1 2021 | -4.67% |
| Q4 2020 | -9.79% |
| Q3 2020 | -4.25% |
| Q2 2020 | 10.36% |
| Q1 2020 | -2.05% |
| Q4 2019 | -3.66% |
| Q3 2019 | -3.43% |
| Q2 2019 | 6641.59% |
| Q1 2019 | 12.69% |
| Q4 2018 | -53.21% |
| Q3 2018 | -34.36% |
| Q2 2018 | 192.40% |
| Q1 2018 | 16.87% |
| Q4 2017 | -52.45% |
| Q3 2017 | -33.93% |
| Q2 2017 | 159.33% |
| Q1 2017 | 91.41% |
| Q4 2016 | -49.65% |
| Q3 2016 | -32.87% |
| Q2 2016 | 48.54% |
| Q1 2016 | -31.20% |